158 related articles for article (PubMed ID: 6190882)
21. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic.
Williams T
Br J Biomed Sci; 1997 Sep; 54(3):181-5. PubMed ID: 9499595
[TBL] [Abstract][Full Text] [Related]
22. Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.
Knibbs LD; Johnson GR; Kidd TJ; Cheney J; Grimwood K; Kattenbelt JA; O'Rourke PK; Ramsay KA; Sly PD; Wainwright CE; Wood ME; Morawska L; Bell SC
Thorax; 2014 Aug; 69(8):740-5. PubMed ID: 24743559
[TBL] [Abstract][Full Text] [Related]
23. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
[TBL] [Abstract][Full Text] [Related]
24. [Routes of the transmission of Pseudomonas aeruginosa infection in resuscitation and intensive therapy departments].
Svirskaia LM
Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):32-4. PubMed ID: 3140543
[TBL] [Abstract][Full Text] [Related]
25. Bacterial contamination in the environment of hospitalised children with cystic fibrosis.
Ferroni A; Werkhauser-Bertrand A; Le Bourgeois M; Beauvais R; Vrielynck S; Durand C; Lenoir G; Berche P; Sermet-Gaudelus I
J Cyst Fibros; 2008 Nov; 7(6):477-82. PubMed ID: 18550452
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.
Speert DP; Campbell ME; Henry DA; Milner R; Taha F; Gravelle A; Davidson AG; Wong LT; Mahenthiralingam E
Am J Respir Crit Care Med; 2002 Oct; 166(7):988-93. PubMed ID: 12359659
[TBL] [Abstract][Full Text] [Related]
27. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.
Wee BA; Tai AS; Sherrard LJ; Ben Zakour NL; Hanks KR; Kidd TJ; Ramsay KA; Lamont I; Whiley DM; Bell SC; Beatson SA
BMC Genomics; 2018 Aug; 19(1):644. PubMed ID: 30165811
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics.
Schmid J; Ling LJ; Leung JL; Zhang N; Kolbe J; Wesley AW; Mills GD; Brown PJ; Jones DT; Laing RT; Pattemore PK; Taylor DR; Grimwood K
Eur Respir J; 2008 Dec; 32(6):1583-90. PubMed ID: 18715877
[TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.
Wolz C; Kiosz G; Ogle JW; Vasil ML; Schaad U; Botzenhart K; Döring G
Epidemiol Infect; 1989 Apr; 102(2):205-14. PubMed ID: 2495226
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation.
Tubbs D; Lenney W; Alcock P; Campbell CA; Gray J; Pantin C
Respir Med; 2001 Feb; 95(2):147-52. PubMed ID: 11217911
[TBL] [Abstract][Full Text] [Related]
31. Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit.
Döring G; Hörz M; Ortelt J; Grupp H; Wolz C
Epidemiol Infect; 1993 Jun; 110(3):427-36. PubMed ID: 8519308
[TBL] [Abstract][Full Text] [Related]
32. Effect of infection with transmissible strains of Pseudomonas aeruginosa on lung transplantation outcomes in patients with cystic fibrosis.
Srour N; Chaparro C; Vandemheen K; Singer LG; Keshavjee S; Aaron SD
J Heart Lung Transplant; 2015 Apr; 34(4):588-93. PubMed ID: 25455752
[TBL] [Abstract][Full Text] [Related]
33. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.
McCallum SJ; Gallagher MJ; Corkill JE; Hart CA; Ledson MJ; Walshaw MJ
Thorax; 2002 Jun; 57(6):559-60. PubMed ID: 12037234
[TBL] [Abstract][Full Text] [Related]
34. Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit.
Mayank D; Anshuman M; Singh RK; Afzal A; Baronia AK; Prasad KN
Indian J Pathol Microbiol; 2009; 52(4):509-13. PubMed ID: 19805958
[TBL] [Abstract][Full Text] [Related]
35. Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.
Clifton IJ; Peckham DG
Expert Rev Respir Med; 2010 Aug; 4(4):519-29. PubMed ID: 20658913
[TBL] [Abstract][Full Text] [Related]
36. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
Pedersen SS; Koch C; Høiby N; Rosendal K
J Antimicrob Chemother; 1986 Apr; 17(4):505-16. PubMed ID: 3086274
[TBL] [Abstract][Full Text] [Related]
37. Genotyping of Pseudomonas aeruginosa sputum and stool isolates from cystic fibrosis patients: evidence for intestinal colonization and spreading into toilets.
Döring G; Bareth H; Gairing A; Wolz C; Botzenhart K
Epidemiol Infect; 1989 Dec; 103(3):555-64. PubMed ID: 2514111
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients.
VanDevanter DR; Van Dalfsen JM; Burns JL; Mayer-Hamblett N
J Pediatric Infect Dis Soc; 2015 Jun; 4(2):151-4. PubMed ID: 26407415
[TBL] [Abstract][Full Text] [Related]
39. Decisions facing the cystic fibrosis clinician at first isolation of Pseudomonas aeruginosa.
Bush A
Paediatr Respir Rev; 2002 Mar; 3(1):82-8. PubMed ID: 12065187
[TBL] [Abstract][Full Text] [Related]
40. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis.
Burdge DR; Nakielna EM; Noble MA
Infect Control Hosp Epidemiol; 1993 Mar; 14(3):127-30. PubMed ID: 7683031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
